317 related articles for article (PubMed ID: 35693346)
21. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
[TBL] [Abstract][Full Text] [Related]
22. Passive Immunization in Alpha-Synuclein Preclinical Animal Models.
Folke J; Ferreira N; Brudek T; Borghammer P; Van Den Berge N
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204668
[TBL] [Abstract][Full Text] [Related]
23. Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy.
Shahnawaz M; Mukherjee A; Pritzkow S; Mendez N; Rabadia P; Liu X; Hu B; Schmeichel A; Singer W; Wu G; Tsai AL; Shirani H; Nilsson KPR; Low PA; Soto C
Nature; 2020 Feb; 578(7794):273-277. PubMed ID: 32025029
[TBL] [Abstract][Full Text] [Related]
24. Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.
Paciotti S; Bellomo G; Gatticchi L; Parnetti L
Front Neurol; 2018; 9():415. PubMed ID: 29928254
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
Singer W
Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
[TBL] [Abstract][Full Text] [Related]
26. Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies.
Magalhães P; Lashuel HA
NPJ Parkinsons Dis; 2022 Jul; 8(1):93. PubMed ID: 35869066
[TBL] [Abstract][Full Text] [Related]
27. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
[TBL] [Abstract][Full Text] [Related]
28. Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies.
Menon S; Armstrong S; Hamzeh A; Visanji NP; Sardi SP; Tandon A
Front Neurol; 2022; 13():852003. PubMed ID: 35614915
[TBL] [Abstract][Full Text] [Related]
29. Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays.
Candelise N; Schmitz M; Thüne K; Cramm M; Rabano A; Zafar S; Stoops E; Vanderstichele H; Villar-Pique A; Llorens F; Zerr I
Transl Neurodegener; 2020; 9():5. PubMed ID: 31988747
[TBL] [Abstract][Full Text] [Related]
30. α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis.
Grossauer A; Hemicker G; Krismer F; Peball M; Djamshidian A; Poewe W; Seppi K; Heim B
Mov Disord Clin Pract; 2023 May; 10(5):737-747. PubMed ID: 37205253
[TBL] [Abstract][Full Text] [Related]
31. Alpha synuclein processing by MMP-3 - implications for synucleinopathies.
Bluhm A; Schrempel S; Moceri S; Stieler J; Feja M; Schilling S; Schulze A; von Hörsten S; Hartlage-Rübsamen M; Richter F; Roßner S
Behav Brain Res; 2022 Sep; 434():114020. PubMed ID: 35870616
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
[TBL] [Abstract][Full Text] [Related]
33. α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications.
Li A; Rastegar C; Mao X
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883550
[TBL] [Abstract][Full Text] [Related]
34. Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators.
Schmitt V; Masanetz RK; Weidenfeller M; Ebbinghaus LS; Süß P; Rosshart SP; von Hörsten S; Zunke F; Winkler J; Xiang W
Behav Brain Res; 2023 Aug; 452():114574. PubMed ID: 37423320
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.
Altay MF; Kumar ST; Burtscher J; Jagannath S; Strand C; Miki Y; Parkkinen L; Holton JL; Lashuel HA
NPJ Parkinsons Dis; 2023 Dec; 9(1):161. PubMed ID: 38062007
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis.
Yoo D; Bang JI; Ahn C; Nyaga VN; Kim YE; Kang MJ; Ahn TB
Parkinsonism Relat Disord; 2022 Nov; 104():99-109. PubMed ID: 36289019
[TBL] [Abstract][Full Text] [Related]
37. Extracellular alpha-synuclein: Sensors, receptors, and responses.
Domingues R; Sant'Anna R; da Fonseca ACC; Robbs BK; Foguel D; Outeiro TF
Neurobiol Dis; 2022 Jun; 168():105696. PubMed ID: 35321855
[TBL] [Abstract][Full Text] [Related]
38. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
[TBL] [Abstract][Full Text] [Related]
39. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.
Koss DJ; Erskine D; Porter A; Palmoski P; Menon H; Todd OGJ; Leite M; Attems J; Outeiro TF
Acta Neuropathol Commun; 2022 Jul; 10(1):98. PubMed ID: 35794636
[TBL] [Abstract][Full Text] [Related]
40. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
Peelaerts W; Baekelandt V
J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
